Tradestie Institutional Equity Comparison Engine

RFDA vs WBIL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RFDA Overall Edge

RFDA Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to RiverFront Dynamic US Dividend Advantage ETF (RFDA) driven by superior Momentum & Technical. Fundamentally, RFDA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus WBIL at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RFDA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against WBIL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RFDA N/M vs WBIL N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner RFDA
1Y +13.8% vs +7.4% ยท 52W Pos 80% vs 49%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RFDA NYSE Arca
RiverFront Dynamic US Dividend Advantage ETF
Institutional Equity
$71.53
-1.15% 1D
Market Cap N/A
1M Return -1.1%
1Y Return +13.84%
Forward P/E N/M
Unified AI Score
60.0 / 100 BUY
Tech 73.0 Fund 61.0 Flow 50.0 Mom 50.0
WBIL NYSE Arca
WBI BullBear Quality 3000 ETF
Institutional Equity
$37.27
-1.03% 1D
Market Cap N/A
1M Return -5.77%
1Y Return +7.38%
Forward P/E N/M
Unified AI Score
59.9 / 100 HOLD
Tech 73.0 Fund 60.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RFDA +13.84% WBIL +7.38% Spread: +6.05 pp (RFDA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RFDA TTM Op. Margin: N/A WBIL TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RFDA vs WBIL. Trailing 12-month operating profitability (RFDA N/A vs WBIL N/A) and valuation multiples (RFDA N/M vs WBIL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RFDA (2) vs WBIL (0)
Institutional Metric RFDA WBIL Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 80% ($61โ€“$74) 49% ($33โ€“$42) Stronger Trend RFDA
Beta / 30D Volatility Risk Regime 0.54ฮฒ ยท 15% Vol 0.89ฮฒ ยท 19% Vol Lower Realized Risk RFDA
Unified Institutional Score Composite Signal 60.0 / 100 (BUY) 59.9 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RFDA vs WBIL Buy Guide
RFDA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RFDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
WBIL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live WBIL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RFDA nor WBIL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.